Gain Therapeutics (GANX) Director Hans P. Hasler Receives Award

What Happened

• Hans P. Hasler, a director of Gain Therapeutics, received a derivative award on 2026-07-15: a 25,000-share option-type grant reported at $0.00 (no cash exchanged at grant). This is a compensation/award transaction, not a purchase or sale.

Key Details

• Transaction date: 2026-07-15; Form 4 filed 2026-07-17 (timely filing).
• Grant details: 25,000 shares (derivative award) reported at $0.00.
• Vesting: The option vests in 12 equal monthly installments beginning July 24, 2026, subject to continuous service (footnote).
• Shares owned after transaction: Not specified in the provided filing.
• No sale or exercise occurred as part of this filing.

Context

• This filing represents an equity compensation grant (an option-style award) to a director. It does not indicate an immediate exercise or sale and therefore is not an indication of a buy/sell market action. Vesting over 12 months means the award becomes exercisable gradually if the director remains in service.